Kamaljit Kaur

Kamaljit Kaur is an Associate Professor at the Chapman University School of Pharmacy (CUSP) in Irvine, California. Previously, she served as an Assistant Professor at the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences (2004–2014).

• Ph.D. in Bioorganic Chemistry, Case Western Reserve University
• Postdoctoral Fellow, Wesleyan University

Research Interests: Engineering peptides for biomedical applications with focus on:

• Peptide-drug conjugates (PDCs) for cancer chemotherapy
• Brain-targeted drug delivery for Alzheimer's Disease
• Antimicrobial peptides against drug-resistant bacteria
• Keratin 1 receptor targeting in breast cancer
• Microcin J25 antimicrobial lasso peptides
• Development of peptide-based biosensors

Publication Trends: Over 75 peer-reviewed articles, 4 book chapters, and 3 approved patents. Key publications include:

• ACS Med. Chem. Lett. (2024): EGFR-binding peptide-doxorubicin conjugates for triple-negative breast cancer
• Neurobiol. Dis. (2024): Hepatic LRP-1 role in Alzheimer's amyloidosis
• Mol. Pharm. (2023): Keratin 1-targeted PDCs for breast cancer
• Pharmaceutics (2022): Melanoma-targeting small peptides
• BBA – Reviews on Cancer (2022): Keratin 1 as cancer receptor

Leadership & Service:

• Editorial Board Member: Scientific Reports and Pharmaceutics
• NIH and CIHR Grant Review Panel
• ACS Medicinal Chemistry Division – Long Range Planning Committee